BioMarin Pharmaceutical | BMRN - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
Agios Pharmaceuticals USD 1.61B 598M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
Bayer EUR 52.42B 5.31B 2026-11
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.95B 667M 2026-11
Gilead Sciences USD 184.82B 27.96B 2026-09
Incyte USD 24.6B 1.95B 2026-09
Insmed USD 24.93B 1.82B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Moderna USD 99.14B 22.26B 2026-11
Neurocrine Biosciences USD 14.46B 45M 2026-11
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 114.34B 15.65B 2026-11
Sarepta Therapeutics USD 1.65B 276M 2026-11
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
United Therapeutics USD 28.64B 5.4B 2026-11
Vertex Pharmaceuticals USD 142.88B 10.37B 2026-11